Cytek Biosciences, Inc. Stock Analysis & AI Score
Cytek Biosciences, Inc. (CTKB) has an ST Score of 51.2 (C+), driven by its Momentum (A-) and held back by its Forecast (C). Analysts rate it Buy with a $4.88 price target (-14.8% downside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Devices |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Cytek Biosciences, Inc. (CTKB) has an ST Score of 51.2 (C+), driven by its Momentum (A-) and held back by its Forecast (C). Analysts rate it Buy with a $4.88 price target (-14.8% downside).
- Strongest
- MomentumA-
- Weakest
- ForecastC
All factor grades
- MomentumA-
- Financial StrengthB+
- ValuationC+
- ProfitabilityC
- GrowthC
- ForecastC
- Piotroski4/9
Contact
CTKB stock: frequently asked questions
What is CTKB's ST Score?
Cytek Biosciences, Inc. (CTKB) has an ST Score of 51.2 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is CTKB a buy, hold, or sell?
Analysts rate CTKB a Buy, with a price target of $4.88 (-14.8% vs the current price). Our ST Score grades it C+ (51.2/100). The ST Score is a data-driven signal, not a recommendation.
What are CTKB's factor grades?
Valuation C+, Profitability C, Financial Strength B+, Momentum A-, Growth C, Forecast C.
What is CTKB's valuation grade?
Cytek Biosciences, Inc. (CTKB) earns a valuation grade of C+, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is CTKB's growth grade?
Cytek Biosciences, Inc. (CTKB) earns a growth grade of C, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is CTKB's profitability grade?
Cytek Biosciences, Inc. (CTKB) earns a profitability grade of C, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is CTKB's financial strength grade?
Cytek Biosciences, Inc. (CTKB) earns a financial strength grade of B+, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for CTKB?
The average analyst price target for Cytek Biosciences, Inc. (CTKB) is $4.88 from 5 analysts, which is -14.8% versus the recent price of $5.73.
What is CTKB's Piotroski score?
Cytek Biosciences, Inc. (CTKB) has a Piotroski F-Score of 4 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.